Highlights Bayer AG

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Market Closed - Xetra Other stock markets 03:57:16 2025-12-12 pm EST			5-day change	1st Jan Change
36.37 ^EUR	-0.10%		+9.20%	+88.31%

Dec. 12	Bayer Wins EU Panel's Recommendation for Eye Disease Drug's New Indication	MT
Dec. 12	BAYER AG : Berenberg reiterates its Neutral rating	ZD

Highlights

Bayer Wins EU Panel's Recommendation for Eye Disease Drug's New Indication	Dec. 12	MT
Berenberg raises target for Bayer to €41 - 'Hold'	Dec. 12	DP
Sumitomo Corporation acquired Metribuzin Solo Business in Latin America, Asia-Pacific and Canada of Bayer Aktiengesellschaft.	Dec. 08	CI
Galmed Pharmaceuticals Ltd. Announces Acceptance of Late-Breaking Abstract to Be Presented at HEP-DART 2025 Meeting	Dec. 08	CI
JPMorgan is also becoming more optimistic: Bayer rally continues	Dec. 08	DP
JPMorgan raises Bayer to 'Overweight' - target doubled	Dec. 08	DP
Bayer Starts Phase IIa Study for Treatment of Patients with Alport Syndrome	Dec. 04	CI
Evotec SE Starts Phase 2 Study for Treatment of Patients with Alport Syndrome	Dec. 04	CI
Bayer Reveals First Results of the Pediatric Study from the Pivotal Clinical Development Program Quanti for Its Low-Dose Mri Contrast Agent	Dec. 03	CI
Bayer: study for gadoquatrane in children meets primary, secondary endpoints	Dec. 03	RE
Bayer back towards previous day's high - Morgan Stanley recommends	Dec. 03	DP
Health Care Down, as Traders Seek Out Risk - Health Care Roundup	Dec. 02	DJ
Frankfurt Stock Exchange closing: DAX gains some ground - Bayer rally	Dec. 02	DP
Bayer Price Target Lifted as Mwb Notes Easing Litigation Overhang	Dec. 02	MT
Bayer Starts New Phase III Study with Mirena®? for the Treatment of Nonatypical Endometrial Hyperplasia	Dec. 02	CI
Financial Stocks, Bayer Lift European Bourses Midday	Dec. 02	MT
Bayer Shares Jump After White House Backs Supreme Court Review in Roundup Case -- Update	Dec. 02	DJ
Bayer at its highest since 2024 – enthusiasm over US news	Dec. 02	DP
JPMorgan leaves Bayer at 'neutral' - target €25	Dec. 02	DP
European shares little changed; Bayer surges on Trump administration backing	Dec. 02	RE
White House Backs Bayer's Bid for Supreme Court Review in Roundup Case	Dec. 02	DJ
Bayer starts new phase III study with Mirena for the treatment of nonatypical endometrial hyperplasia	Dec. 02	RE
Goldman maintains Bayer at 'Buy' - target price €38.50	Dec. 02	DP
Bayer jumps to annual high – Good news from the US Department of Justice	Dec. 02	DP
US Solicitor General Backs Bayer Over Supreme Court Review in Roundup Case	Dec. 01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Bayer benefits from Q3 earnings beat and steady outlook

November 12, 2025 at 01:03 pm EST

Bayer, close to the final round(up)?

June 05, 2025 at 10:56 am EDT

Roundup: Bayer ordered to pay $2.1bn to an American suffering from cancer

March 24, 2025 at 06:21 am EDT